TEVA PHARMACEUTICAL INDUSTRIES LIMITED Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number of 11.87 million shares as of 2025-12-31, per its 10-K filed 2026-02-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber · last filed 2026-02-03
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 11.87M shares.
- 2024-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 17.71M shares.
- 2023-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 22.70M shares.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number 24.12M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number |
|---|---|
| 2025-12-31 | 11.87M shares 10-K · filed 2026-02-03 |
| 2024-12-31 | 17.71M shares 10-K · filed 2026-02-03 |
| 2023-12-31 | 22.70M shares 10-K · filed 2026-02-03 |
| 2022-12-31 | 24.12M shares 10-K · filed 2025-02-05 |
| 2021-12-31 | 26.99M shares 10-K · filed 2024-02-12 |
| 2020-12-31 | 28.56M shares 10-K · filed 2023-02-10 |
| 2019-12-31 | 26.60M shares 10-K · filed 2022-02-09 |
| 2018-12-31 | 24.09M shares 10-K · filed 2021-02-10 |
| 2017-12-31 | 19.13M shares 10-K · filed 2020-02-21 |
| 2016-12-31 | 14.47M shares 10-K · filed 2019-02-19 |